MYO1G and acute lymphoblastic leukemia: We found that Myo1g is over expressed at mRNA and to some extent at protein level in PBMCs from ALL patients and identified Myo1g as a molecule that participates in the course of the disease, we suggest that it is involved in the pathogenesis of the pediatric ALL.